Business Investment Opportunities in Singapore

Edtech business involved in the early childhood education industry. - Customization of the school's curriculum. - Marketplace for preschool service providers. - Ecosystem with all stakeholders. - 10,000 paid students user from Beta launch. - The business holds a valid registration with the local government body.

The company has pioneered the first blood-based cancer detection tests capable of identifying up to 30 common cancers. - We have consistently focused on innovative solutions for early-stage cancer detection to significantly reduce cancer-related deaths. - The company employs an ingenious approach that combines cutting-edge experimental tools with the latest advancements in deep learning methodologies. - With the global rise in cancer incidence, annual cancer deaths have also increased significantly. - Most cancers are diagnosed at late stages due to the absence of early clinical symptoms, leading to poor prognosis. - Early detection of cancer can reduce mortality by up to 70%, yet no current methods accurately detect cancer at early stages. - We have leveraged this opportunity by developing a groundbreaking blood test that detects 30 cancers in both males and females. - Our product integrates molecular mapping of the physiological state with a deep learning platform to identify cancer-specific molecular signatures. - The test is a novel, non-invasive blood-based screening method capable of detecting cancers and identifying the tissue of origin from the same sample. - The 30 cancers detected represent about 90% of new cancer cases each year. - Our test has achieved an unmatched accuracy of over 98% for early-stage cancer detection. - This advancement can significantly reduce the global cancer mortality burden. - The company is in the process of commercializing the test. - The promoter have over 40+ years of experience in the industry. - Licenses include CIN, SSM and GST. We have also applied for a USFDA. We have applied to the DCGI (Drugs Controller General of India) for market approval in India. We will launch operations post the DCGI approval. - Our target audience includes hospitals in India and Singapore. - Our R&D headquarters are in Haryana, with global headquarters in Singapore. - We also maintain an office in Singapore with dedicated staff.

Singapore's No. 1 premium pet brand seeking investments to accelerate growth across petcare verticals. - Primary sales will be from the sale of live pets (dogs, cats) and pet care products in Singapore. - We have a database of over 1,000+ members in our exclusive club for fur babies, through our other ventures. - Projected annual revenue of SGD 1.8 million with 26% EBITDA at 80% capacity. - Strategic investment opportunity will be in the newly incorporated business, the investor would not get shares in our ongoing ancillary ventures. - Post funding, we plan to launch operations, currently obtaining licenses. We will launch in 2.5 months once we have raised funds. - Promoters bring 6 years of industry experience.

Empowering enterprises with transformative product engineering services. - Our product engineering skillsets have attracted customers from Silicon Valley and reputed companies like Temasek Foundation in Singapore. - We have two ready-to-go IPs, never actively marketed, but with the potential to expand and get listed on the Singapore Stock Exchange within five years. - We hold 70% of the industrial housing software market share in Singapore. - Several top-notch real estate companies use our services. - We have 15 active projects in the Singapore market alone. - Singapore serves as our regional HQ for the Far East. - We have established subsidiaries in Malaysia and Thailand. - Experienced team of 30 engineers is based in Bangalore. - Current investment is focused on boosting sales in the Singapore market. - We could easily achieve SGD 2M in revenue with an additional SGD 100k investment in Singapore sales. - We are seeking long-term investors who can potentially reap 10X returns on their investments. - Our goal is to list the company on SGX within five years. - Technologies are cloud-based and we are fully licensed, including ACRA registration. - The owner travels frequently between Singapore and India, and we have a resident director in Singapore. - We have a strong clientele and have excelled in delivering competitive IT projects, with marketing efforts primarily focused on Singapore. - Our product is integrated with the Government of Singapore (MOM) and is utilized by major private dorm operators. Additionally, our products are used by various commercial fleets in Singapore.

The business operates in the spa industry in Singapore, offering a range of Ayurvedic spa treatments, including Shirodhara, Abhyanga, and salt therapy. In addition to its core services, the business offers holistic therapies, detox programs, relaxing retreats, well-being workshops, and yoga sessions, diversifying its revenue streams and attracting a broader customer base. The spa has over 20 treatment rooms available, indicating a capacity to cater to a significant number of clients simultaneously. With an average of 20 walk-in customers daily, the business demonstrates a steady flow of foot traffic, suggesting a healthy level of demand for its services. The wellness center boasts a customer base of over 10,000 individuals, indicating a strong brand presence and customer loyalty over the 4 years of operation. The business has a membership program with over 1,000 active members, highlighting a recurring revenue stream and a loyal customer base. The spa holds a valid business operation license, ensuring compliance with regulatory requirements and providing a foundation for sustainable operations.

Prominent game publisher and collective of studios, recognized for selling over 50,000 copies and earning multiple prestigious awards. - Our games are distributed digitally across leading platforms such as Steam (primary), Playstation Store, Xbox Store, Nintendo eShop, Android Play Store, and iOS App Store. - Our revenue streams from in-game purchases and distribution fees. - We cater to a diverse global demographic, targeting ages 16-45. - Our customer base is global, with players divided across North America (32.9%), Western Europe (21.9%), and Asia (31.6%). - Players purchase and download them digitally through digital storefronts for an upfront purchase price of US$15-US$30 per copy. - Players can purchase and download them digitally through digital storefronts. - To date, we have successfully launched 5 engaging titles. - Our experienced promoter boasts a decade of industry expertise. - Licensed under SSM, ensuring compliance and credibility in our operations. - Our 5 successfully released games have sold over tens of thousands of copies and garnered multiple international awards, captivating a diverse global audience. - We are currently expanding through the recent acquisition of 2 promising local game studios and the in-house R&D of new game titles, resulting in a break-even operational state.

Specialize in OEM manufacturing for diabetic medicines catering to hospitals and research institutions. - Established client base includes Malaysian royalty and export to the lucrative China market. - Profitable operations with plans for expansion. - Conducted clinical trials in collaboration with NUH (National University Hospital) for diabetic treatments. - Collaborative research and development projects with NYP (Nanyang Polytechnic) for the Chinese market. - Multiple ongoing projects in the pipeline for further product development. - Diverse client base spanning healthcare and research institutions, totaling 300 in China alone. - Manufacturing capacity capable of producing 500 bottles/day of diabetic medications. - Bringing 10 years of industry experience to the table. - Fully licensed and compliant with ISO standards, with additional certifications including incorporation, factory license, and halal certification.